Association of DDX58 177 C > T polymorphism with decreased risk of Epstein–Barr virus-related nodular sclerosis classical Hodgkin lymphoma

References

• Roschewski M, Wilson WH. EBV-associated lymphomas in adults. Best Pract Res Clin Haematol. 2012;25:75–89.
   PubMed Web of Science ®Google Scholar
• Glaser SL, Lin RJ, Stewart SL, et al. Epstein-Barr virus-associated Hodgkin’s disease: epidemiologic characteristics in international data. Int J Cancer. 1997;70:375–382.
   PubMed Web of Science ®Google Scholar
• Cader FZ, Kearns P, Young L, et al. The contribution of the Epstein-Barr virus to the pathogenesis of childhood lymphomas. Cancer Treat Rev. 2010;36:348–353.
   PubMed Web of Science ®Google Scholar
• Niens M, Jarrett RF, Hepkema B, et al. HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV + Hodgkin lymphoma. Blood. 2007;110:3310–3315.
   PubMed Web of Science ®Google Scholar
• Huang X, Kushekhar K, Nolte I, et al. HLA associations in classical Hodgkin lymphoma: EBV status matters. PLoS One. 2012;7:e39986.
   PubMed Web of Science ®Google Scholar
• Martin P, Krsnik I, Navarro B, et al. HLA allele E*01:01 is associated with a reduced risk of EBV-related classical hodgkin lymphoma independently of HLA-A*01/*02. PLoS One. 2015;10:e0135512.
   PubMed Web of Science ®Google Scholar
• Kushekhar K, van den Berg A, Nolte I, et al. Genetic associations in classical Hodgkin lymphoma: a systematic review and insights into susceptibility mechanisms. Cancer Epidemiol Biomarkers Prev. 2014;23:2737–2747.
   PubMed Web of Science ®Google Scholar
• van Gent M, Braem SG, de Jong A, et al. Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling. PLoS Pathog. 2014;10:e1003960.
   PubMed Web of Science ®Google Scholar
• van Gent M, Griffin BD, Berkhoff EG, et al. EBV lytic-phase protein BGLF5 contributes to TLR9 downregulation during productive infection. J Immunol. 2011;186:1694–1702.
   PubMed Web of Science ®Google Scholar
• Iwakiri D, Zhou L, Samanta M, et al. Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3. J Exp Med. 2009;206:2091–2099.
   PubMed Web of Science ®Google Scholar
• Samanta M, Iwakiri D, Kanda T, et al. EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN. EMBO J. 2006;25:4207–4214.
   PubMed Web of Science ®Google Scholar
• Chetaille B, Bertucci F, Finetti P, et al. Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome. Blood. 2009;113:2765–3775.
   PubMed Web of Science ®Google Scholar
• Satoh T, Wada R, Yajima N, et al. Tumor microenvironment and RIG-I signaling molecules in Epstein Barr virus-positive and -negative classical Hodgkin lymphoma of the elderly. J Clin Exp Hematop. 2014;54:75–84.
   PubMedGoogle Scholar
• Pott J, Mahlakoiv T, Mordstein M, et al. IFN-lambda determines the intestinal epithelial antiviral host defense. Proc Natl Acad Sci USA. 2011;108:7944–7949.
   PubMed Web of Science ®Google Scholar
• Mordstein M, Neugebauer E, Ditt V, et al. Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol. 2010;84:5670–5677.
   PubMed Web of Science ®Google Scholar
• Lazarus R, Klimecki WT, Raby BA, et al. Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case-control disease association studies. Genomics. 2003;81:85–91.
   PubMed Web of Science ®Google Scholar
• Mollaki V, Georgiadis T, Tassidou A, et al. Polymorphisms and haplotypes in TLR9 and MYD88 are associated with the development of Hodgkin’s lymphoma: a candidate-gene association study. J Hum Genet. 2009;54:655–659.
   PubMed Web of Science ®Google Scholar
• Nahum A, Dadi H, Bates A, et al. The biological significance of TLR3 variant, L412F, in conferring susceptibility to cutaneous candidiasis, CMV and autoimmunity. Autoimmun Rev. 2012;11:341–347.
   PubMed Web of Science ®Google Scholar
• Yang CA, Raftery MJ, Hamann L, et al. Association of TLR3-hyporesponsiveness and functional TLR3 L412F polymorphism with recurrent herpes labialis. Hum Immunol. 2012;73:844–851.
   PubMed Web of Science ®Google Scholar
• Thomas DL, Thio CL, Martin MP, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature. 2009;461:798–801.
   PubMed Web of Science ®Google Scholar
• Suppiah V, Moldovan M, Ahlenstiel G, et al. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet. 2009;41:1100–1104.
   PubMed Web of Science ®Google Scholar
• Prokunina-Olsson L, Muchmore B, Tang W, et al. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet. 2013;45:164–171.
   PubMed Web of Science ®Google Scholar
• Hu J, Nistal-Villan E, Voho A, et al. A common polymorphism in the caspase recruitment domain of RIG-I modifies the innate immune response of human dendritic cells. J Immunol. 2010;185:424–432.
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008.
   Google Scholar
• Lee JH, Kim Y, Choi JW, et al. Prevalence and prognostic significance of Epstein-Barr virus infection in classical Hodgkin’s lymphoma: a meta-analysis. Arch Med Res. 2014;45:417–431.
   PubMed Web of Science ®Google Scholar
• Flavell KJ, Biddulph JP, Constandinou CM, et al. Variation in the frequency of Epstein-Barr virus-associated Hodgkin’s disease with age. Leukemia. 2000;14:748–753.
   PubMed Web of Science ®Google Scholar
• Barros MH, Vera-Lozada G, Soares FA, et al. Tumor microenvironment composition in pediatric classical Hodgkin lymphoma is modulated by age and Epstein-Barr virus infection. Int J Cancer. 2012;131:1142–1152.
   PubMed Web of Science ®Google Scholar
• Jarrett RF, Gallagher A, Jones DB, et al. Detection of Epstein-Barr virus genomes in Hodgkin’s disease: relation to age. J Clin Pathol. 1991;44:844–848.
   PubMed Web of Science ®Google Scholar
• Huang X, Nolte I, Gao Z, et al. Epidemiology of classical Hodgkin lymphoma and its association with Epstein Barr virus in Northern China. PLoS One. 2011;6:e21152.
   PubMed Web of Science ®Google Scholar
• Tomita Y, Ohsawa M, Kanno H, et al. Epstein-Barr virus in Hodgkin’s disease patients in Japan. Cancer. 1996;77:186–192.
   PubMed Web of Science ®Google Scholar
• Park CS, Juhng SW, Brigati DJ, et al. Analysis of Epstein-Barr virus in Hodgkin’s disease: experience of a single university hospital in Korea. J Clin Lab Anal. 1994;8:412–417.
   PubMed Web of Science ®Google Scholar
• Glaser SL, Gulley ML, Clarke CA, et al. Racial/ethnic variation in EBV-positive classical Hodgkin lymphoma in California populations. Int J Cancer. 2008;123:1499–1507.
   PubMed Web of Science ®Google Scholar
• Zarate-Osorno A, Roman LN, Kingma DW, et al. Hodgkin’s disease in Mexico. Prevalence of Epstein-Barr virus sequences and correlations with histologic subtype. Cancer. 1995;75:1360–1366.
   PubMed Web of Science ®Google Scholar
• Chang KL, Albujar PF, Chen YY, et al. High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of Hodgkin’s disease occurring in Peru. Blood. 1993;81:496–501.
   PubMed Web of Science ®Google Scholar
• Vassallo J, Metze K, Traina F, et al. Expression of Epstein-Barr virus in classical Hodgkin’s lymphomas in Brazilian adult patients. Haematologica. 2001;86:1227–1228.
   PubMed Web of Science ®Google Scholar
• Enblad G, Sandvej K, Sundstrom C, et al. Epstein-Barr virus distribution in Hodgkin’s disease in an unselected Swedish population. Acta Oncol. 1999;38:425–429.
   PubMed Web of Science ®Google Scholar
• Glaser SL, Clarke CA, Chang ET, et al. Hodgkin lymphoma incidence in California Hispanics: influence of nativity and tumor Epstein-Barr virus. Cancer Causes Control. 2014;25:709–725.
   PubMed Web of Science ®Google Scholar
• Moumad K, Lascorz J, Bevier M, et al. Genetic polymorphisms in host innate immune sensor genes and the risk of nasopharyngeal carcinoma in North Africa. G3 (Bethesda). 2013;3:971–977.
   PubMedGoogle Scholar